M.P. Schneider

Discipline

Psychologie (4) Economies et finances (2) Sociologie (1) Anthropologie biologique (1)

Type de document

Articles (24) Recensions (5) Colloques et conférences (3)

Co-auteur

Date

Source

Mot-clé

Patients (20) Treatment (17) Patients (17) temps (durée) (9) thérapie (9) Time (9) Therapeutics (9) Analysis (9) surveillance (8) analyse (8) Monitoring (8) Months (8) Human beings (8) recherche (7) Research (7) Research (7) Age (7) âge (6) Ci (Chinese poetry) (6) Swiss (6) Pharmacy (6) Management (6) Impact (6) Example (6) Evaluation (6) Age (6) persistance (5) Interviews (5) Risk (5) Pharmacists (5)

Documents écrit par M.P. Schneider (27) | parle de M.P. Schneider (0)

Estimation of adherence to medication treatment in presence of censoring.
J. Pasquier et al.
L’ordonnance : messager entre la personne, le cabinet médical, l’équipe infirmière et la pharmacie. Introduction à la collaboration interprofessionnelle [The prescription: messenger between the person, the doctor's office, the nursing and pharmacy teams]
N. Jaunin-Stalder et al. (31 mai 2023)
Néphropathie diabétique : soutenir l’adhésion médicamenteuse de façon interprofessionnelle [Diabetic nephropathy: Interprofessional support of medication adherence]
C. Bandiera et al. (31 mai 2023)
Se former à l’entretien motivationnel pour mieux soutenir l’adhésion thérapeutique des patients [Learning motivational interviewing to better support patient medication adherence]
T. Novais et al. (19 avr. 2023)
Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study.
C. Bandiera et al. (3 janv. 2023)
Understanding reasons and factors for participation and non-participation to a medication adherence program for patients with diabetic kidney disease in Switzerland: a mixed methods study.
C. Bandiera et al. (27 sept. 2022)
Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer.
P. Courlet et al. (21 juin 2022)
Medication Adherence Evaluated Through Electronic Monitors During the 2020 COVID-19 Pandemic Lockdown in Switzerland: A Longitudinal Analysis.
C. Bandiera et al. (2022)
Swiss Priority Setting on Implementing Medication Adherence Interventions as Part of the European ENABLE COST Action.
C. Bandiera et al. (2022)
Forgiveness of Dolutegravir-Based Triple Therapy Compared With Older Antiretroviral Regimens: A Prospective Multicenter Cohort of Adherence Patterns and HIV-RNA Replication.
J.J. Parienti et al.
Longitudinal analysis of safety and medication adherence of patients in the Fingolimod patient support program: a real-world observational study.
A. Bourdin et al. (18 févr. 2021)
Association of Incomplete Adherence to Antiretroviral Therapy With Cardiovascular Events and Mortality in Virologically Suppressed Persons With HIV: The Swiss HIV Cohort Study.
J.R. Castillo-Mancilla et al.
An Adherence-Enhancing Program Increases Retention in Care in the Swiss HIV Cohort.
S. Kamal et al.
Implementation of an interprofessional medication adherence program for chronic patients in community pharmacies: how much does it cost for the provider?
C. Perraudin et al. (8 janv. 2019)
A Novel Approach to Better Characterize Medication Adherence in Oral Anticancer Treatments.
M.P. Schneider et al. (2019)
Implementation study of an interprofessional medication adherence program for HIV patients in Switzerland: quantitative and qualitative implementation results.
M. Lelubre et al. (20 nov. 2018)
Implementation of an interprofessional medication adherence program for HIV patients: description of the process using the framework for the implementation of services in pharmacy.
M. Lelubre et al. (10 sept. 2018)
Assessment of medication adherence and responsible use of isotretinoin and contraception through Belgian community pharmacies by using pharmacy refill data.
N. Biset et al. (2018)
HIV-infected patients' beliefs about their chronic co-treatments in comparison with their combined antiretroviral therapy.
S. Kamal et al.
La dimension expérientielle des médicaments antirétroviraux dans les traitements du VIH
N. Genre et al. (19 avr. 2017)
The Presence of Human Immunodeficiency Virus-Associated Neurocognitive Disorders Is Associated With a Lower Adherence to Combined Antiretroviral Treatment.
S. Kamal et al. (2017)
Immunosuppressive therapy after solid-organ transplantation: does the INTERMED identify patients at risk of poor adherence?
L. Michaud et al. (2016)
Cyberhealth serving to support individual intake of medication.
M.P. Schneider et al. (2013)
Programme interdisciplinaire de soutien de l'adhésion thérapeutique : une expérience lausannoise réussie
M.P. Schneider (2011)
Oral cancer treatments and compliance : MEMS® assessment for capecitabine, letrozole and exemestane
L. Achtari Jeanneret et al. (2010)

next